The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
May 1, 2016|
Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?